News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Antibody Therapy Targets Cancer Stem Cells: Study
Joshua A. Krisch | Mar 15, 2017
CT16 appears to eliminate cancer stem cells more effectively than radiation therapy in vitro and has shown promise in mice.
Unique Antibodies Open Path Toward New HIV Vaccines
Amanda B. Keener | Jan 27, 2017
A family of broadly neutralizing antibodies from a chronically infected donor provides a schematic for designing vaccines and treatments that target multiple strains of the virus.
Toward an Immunotherapy for Alzheimer’s Disease
Tanya Lewis | Jul 28, 2016
Targeting tau antibodies does not require effector function, researchers report.
Vaccines Protect Mice Against Zika Infection
Alison F. Takemura | Jun 29, 2016
Two different vaccines confer complete immunity for two months, researchers report.
Zika and Dengue Immunity: A Complex Relationship
Amanda B. Keener | Jun 28, 2016
Researchers examine the blood of people infected with dengue virus, finding a few Zika-neutralizing antibodies among mostly enhancing ones.
Antibody Maker Loses License Over Animal Welfare Violations
Jef Akst | May 23, 2016
The US Department of Agriculture orders Santa Cruz Biotechnology to pay a $3.5 million fine and to cease selling research antibodies.
Tasmanian Devil Antibodies Fight Cancer
Jef Akst | May 9, 2016
The proteins could be the key to stopping the transmissible facial tumor disease that is threatening the species.
Dengue Antibodies Enhance Zika Infection?
Tanya Lewis | Apr 28, 2016
Previous flavivirus infection could help explain the severity of symptoms in some people infected during the ongoing Zika outbreak, researchers report.
In Situ Antibodies
Jyoti Madhusoodanan | Feb 2, 2016
Compared with systemic injections, localized antibody therapies may be more effective for some indications.
Building Better Reagents
Jane McLeod, Paul Ko Ferrigno | Feb 1, 2016
Facing problems of inconsistent, time-consuming, and costly antibody production, some researchers are turning to alternatives to target specific proteins of interest, in the lab and in the clinic.